Strategic Rationale: Evaluation of the transaction’s core logic, focusing on market synergy, operational integration, and the long-term strategic alignment of the combined entity.
Target Overview: A summary of the target company’s business model, key offerings, and the specific value it adds to the acquirer’s portfolio.
Deal Dynamics: Breakdown of the transaction structure, including purchase price, financing methods, and the resulting pro-forma ownership.
Accretion/Dilution Analysis: Evaluation of the deal’s impact on Earnings Per Share, synergy realisations, and the combined entity’s projected valuation.
Deal Size: $14.5B.
Industry: Medical Devices.
EBITDA Multiple: 60.3x EBITDA.
Financing: 73% Cash and 27% Stock transaction.
Deal Size: $53B.
Industry: Oil & Gas.
EBITDA Multiple: 8.1x EBITDA.
Financing: 100% Stock Transaction.
Deal Size: $1.25B.
Industry: Health Care Technology.
EBITDA Multiple: 11.6x EBITDA.
Financing: 50% Cash and 50% Stock.
Deal Size: $3.3B.
Industry: Managed Health Care/Health Care Services.
EBITDA Multiple: 15.2x EBITDA.
Financing: 100% Cash Transaction.
Cascade Research is an independent, student-run organisation formed by students of University College London. It is not affiliated with or endorsed by UCL. All content is for educational and research demonstration only and does not constitute investment advice.
@2025 All Rights Reserved Cascase Research